Diastolic Pressure Could Play a Dirty Trick on Patients Treated for Hypertension

Having too low diastolic pressure could be linked to an increase in cardiovascular events (J-shape phenomenon). However, current guidelines suggest a target blood pressure under 130/80 mmHg with no lower limit for diastolic pressure.

Las nuevas guías Europeas de Hipertensión contrastan con las Americanas

This paper, recently published in JAMA, sought to evaluate the J-shape phenomenon of diastolic pressure in treated patients who reached a target systolic pressure under 130 mmHg—as guidelines recommend.

The cohort of patients was divided into the following intervals of diastolic pressure: less than 60 mmHg, between 60 and 70 mmHg, between 70 and 80 mmHg, and more than 80 mmHg.

The study’s primary endpoint was a composite of all-cause mortality, myocardial infarction, and stroke. The secondary endpoint included death due to cardiovascular causes, infarction, and non-fatal stroke.

The analysis included 7515 patients with a mean age of 65.6 years.

The lower risk for events was observed in patients with a diastolic pressure between 70 and 80 mmHg.


Read also: What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg.


A mean diastolic pressure under 60 mmHg was linked to a significant increase in the primary endpoint risk (hazard ratio [HR]: 1.46; 95% confidence interval [CI]: 1.13-1.90; p = 0.004).

In relation to the composite, it was even more significant: death for cardiovascular causes (HR: 1.74; 95% CI: 1.26-2.41; p = 0.001), non-fatal stroke (HR: 1.73; 95% CI: 1.15-2.59; p = 0.008), and non-fatal stroke (HR 2.67; 95% CI: 1.26-5.63; p = 0.01).

Conclusion

This cohort study showed that a too low diastolic pressure (under 60 mmHg) was associated with an increase in cardiovascular events in treated patients who had reached a target systolic pressure of 130 mmHg or less.

The finding of an ideal systolic pressure between 70 and 80 mmH should be studied further.

li_2021_oi_201127_1612905985-33781

Original Title: Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.

Reference: Jingen Li et al. JAMA Network Open. 2021;4(2):e2037554. doi:10.1001/jamanetworkopen.2020.37554.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...